Analysed BELITE BIO INC - ADR (BLTE:NASDAQ) News Sources
Belite Bio Inc (BLTE) Q1 2026 Earnings Call Highlights: Strategic Advancements Amid Rising Expenses
21-05-2026
yahoo.com
Belite Bio to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
02-06-2026
yahoo.com
Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
13-06-2026
yahoo.com
Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium
06-07-2026
yahoo.com
Belite Bio Eyes Priority FDA Review as Tinlarebant Targets Stargardt Disease
10-07-2026
marketbeat.com
Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
15-07-2026
yahoo.com
Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1
20-07-2026
yahoo.com
What is the current price of BELITE BIO INC - ADR (BLTE:NASDAQ)?
The current price of BELITE BIO INC - ADR (BLTE:NASDAQ) is $155.95.
BELITE BIO INC - ADR (BLTE:NASDAQ) absolute price change since previous trading day?
The absolute price change of BELITE BIO INC - ADR (BLTE:NASDAQ) since the previous trading day is $-2.48.
BELITE BIO INC - ADR (BLTE:NASDAQ) percentage price change since previous trading day?
The percentage price change of BELITE BIO INC - ADR (BLTE:NASDAQ) since the previous trading day is -1.5654%.
What is the most recent average sentiment score for BELITE BIO INC - ADR (BLTE:NASDAQ)?
The most recent average sentiment score for BELITE BIO INC - ADR (BLTE:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for BELITE BIO INC - ADR (BLTE:NASDAQ)?
The most recent sentiment for BELITE BIO INC - ADR (BLTE:NASDAQ) is .
SEC-8K** Filing Available For BELITE BIO INC - ADR (BLTE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.